ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,814.40
-0.85%
S&P ASX All Technology
3,045.20
-2.07%
Brent Oil
83.76
0.00%
US Dollar vs AUD
1.49165
0.00%
Bitcoin
67,037.33
0.14%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Cassava Sciences Inc (SAVA)

  7. Cassava Sciences Inc (SAVA) News

SAVA

Cassava Sciences (SAVA)

Cassava Sciences Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:SAVA
DateTimeSourceHeadlineSymbolCompany
11/05/202406:02GlobeNewswire Inc.Cassava Sciences Reports Q1 2024 Financial Results and Clinical Updates on Phase 3 Trials of SimufilamNASDAQ:SAVACassava Sciences Inc
09/05/202401:00GlobeNewswire Inc.Cassava Sciences Announces Over $125 Million Raised from Warrant DistributionNASDAQ:SAVACassava Sciences Inc
01/05/202423:10GlobeNewswire Inc.Tomorrow is Last Day to Trade SAVAW Warrants on NASDAQNASDAQ:SAVACassava Sciences Inc
15/04/202423:20GlobeNewswire Inc.Redemption Date Announced for WarrantsNASDAQ:SAVACassava Sciences Inc
26/03/202400:13GlobeNewswire Inc.Cassava Sciences Announces Completion of an Interim Safety Review of Oral Simufilam On-going Phase 3 TrialsNASDAQ:SAVACassava Sciences Inc
05/03/202401:15GlobeNewswire Inc.Cassava Sciences Announces Virtual Presentation at the AD/PD™ 2024 International ConferenceNASDAQ:SAVACassava Sciences Inc
29/02/202408:01Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:SAVACassava Sciences Inc
29/02/202401:22Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SAVACassava Sciences Inc
29/02/202401:14GlobeNewswire Inc.Cassava Sciences Reports Full-year 2023 Financial Results and Corporate UpdatesNASDAQ:SAVACassava Sciences Inc
08/02/202401:20Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SAVACassava Sciences Inc
08/02/202401:08GlobeNewswire Inc.No Decline in Cognition Scores in Patients with Mild Alzheimer's Disease Who Received Simufilam Continuously For 24 MonthsNASDAQ:SAVACassava Sciences Inc
02/02/202408:00Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:SAVACassava Sciences Inc
27/01/202408:23Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:SAVACassava Sciences Inc
06/01/202401:12GlobeNewswire Inc.Cassava Sciences Completes Dividend Distribution of Warrants to ShareholdersNASDAQ:SAVACassava Sciences Inc
04/01/202408:24Edgar (US Regulatory)Form CERT - Certification by an exchange approving securities for listingNASDAQ:SAVACassava Sciences Inc
04/01/202408:22Edgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]NASDAQ:SAVACassava Sciences Inc
04/01/202408:18Edgar (US Regulatory)Form 8-A12B - Registration of securities [Section 12(b)]NASDAQ:SAVACassava Sciences Inc
04/01/202401:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SAVACassava Sciences Inc
03/01/202401:10Edgar (US Regulatory)Form 8-A12G - Registration of securities [Section 12(g)]NASDAQ:SAVACassava Sciences Inc
13/12/202301:19Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SAVACassava Sciences Inc
13/12/202301:13GlobeNewswire Inc.Cassava Sciences Announces Dividend Distribution of Warrants to ShareholdersNASDAQ:SAVACassava Sciences Inc
12/12/202308:18Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SAVACassava Sciences Inc
09/12/202309:06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SAVACassava Sciences Inc
09/12/202309:04Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:SAVACassava Sciences Inc
08/12/202308:57Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SAVACassava Sciences Inc
08/12/202308:55Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SAVACassava Sciences Inc
08/12/202308:52Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:SAVACassava Sciences Inc
08/12/202308:24Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:SAVACassava Sciences Inc
08/12/202308:01GlobeNewswire Inc.Cassava Sciences Appoints Three New Members to its Board of DirectorsNASDAQ:SAVACassava Sciences Inc
08/11/202301:19Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SAVACassava Sciences Inc
 Showing the most relevant articles for your search:NASDAQ:SAVA

Your Recent History

COIN
SCTKETH
COIN
BMTSETH
BitMinutes
ASX
WDIV
SPDR S&P Global Dividend
NASDAQ
ISOT
COIN
MITXETH
Morpheus Infrastructure Token
COIN
ISLAETH
Insula
AMEX
BMAR
Innovator US Equity Buff...
HUOB
RDNETH
Raiden
NASDAQ
PONO
Pono Capital
LATK
REVAUSDT
Reva Token
AMEX
CFF
Centrue Financial
NASDAQ
ECAV
NASDAQ
VUSXX
Vanguard Admiral Fund Treasury M
LATK
GRETUSDT
Global REIT
LSE
PJIA
LSE
38LP
Ash. Cap 22 A
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved